Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Smyth

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
The Lancet. Oncology|February 3, 2020
Chemotherapy for resectable microsatellite instability-high gastric cancer?Elizabeth C Smyth
Translational Gastroenterology and Hepatology|April 28, 2017
Regorafenib in gastric cancerElizabeth C Smyth
Personalized Medicine|May 12, 2018
Personalizing the management of gastroesophageal cancerElizabeth C Smyth
Therapeutic Advances in Medical Oncology|March 2, 2016
Novel targets in the treatment of advanced gastric cancer: a perspective reviewElisa Fontana, Elizabeth C Smyth
Journal of Personalized Medicine|June 24, 2022
Immunotherapy for Squamous Esophageal Cancer: A ReviewAngelica Petrillo, Elizabeth C Smyth
The Lancet. Gastroenterology & Hepatology|March 16, 2024
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancerRaghav Sundar, Elizabeth C Smyth
ESMO Open|November 19, 2020
Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answerElizabeth C Smyth, Andrés Cervantes
Visceral Medicine|November 12, 2020
Biomarkers for Precision Treatment in Gastric CancerAngelica Petrillo, Elizabeth C Smyth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Epirubicin, Cisplatin, and Capecitabine Versus Fluorouracil, Leucovorin, and Irinotecan for Esophagogastric Cancer: The Original and the RestElizabeth C Smyth, David Cunningham
Journal of Thoracic Disease|December 10, 2017
Neoadjuvant DCF <i>vs.</i> ACF for resectable oesophageal squamous cell carcinomaVasiliki Michalarea, Elizabeth C Smyth
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|February 3, 2020
Chemotherapy for resectable microsatellite instability-high gastric cancer?Elizabeth C Smyth
Translational Gastroenterology and Hepatology|April 28, 2017
Regorafenib in gastric cancerElizabeth C Smyth
Personalized Medicine|May 12, 2018
Personalizing the management of gastroesophageal cancerElizabeth C Smyth
Therapeutic Advances in Medical Oncology|March 2, 2016
Novel targets in the treatment of advanced gastric cancer: a perspective reviewElisa Fontana, Elizabeth C Smyth
Journal of Personalized Medicine|June 24, 2022
Immunotherapy for Squamous Esophageal Cancer: A ReviewAngelica Petrillo, Elizabeth C Smyth
The Lancet. Gastroenterology & Hepatology|March 16, 2024
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancerRaghav Sundar, Elizabeth C Smyth
ESMO Open|November 19, 2020
Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answerElizabeth C Smyth, Andrés Cervantes
Visceral Medicine|November 12, 2020
Biomarkers for Precision Treatment in Gastric CancerAngelica Petrillo, Elizabeth C Smyth
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Epirubicin, Cisplatin, and Capecitabine Versus Fluorouracil, Leucovorin, and Irinotecan for Esophagogastric Cancer: The Original and the RestElizabeth C Smyth, David Cunningham
Journal of Thoracic Disease|December 10, 2017
Neoadjuvant DCF <i>vs.</i> ACF for resectable oesophageal squamous cell carcinomaVasiliki Michalarea, Elizabeth C Smyth
Pageof 12